Consensus statement: Recommendations for reporting cost-effectiveness analyses

Pediatric AIDS and HIV Infection

Volumn 8, Issue 2, 1997, Pages 130-134

  Siegel, Joanna E ^a,b   Weinstein, Milton C ^a,b   Russell, Louise B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH SERVICE; PRACTICE GUIDELINE; PUBLIC HEALTH;

EID: 0030919710     PISSN: 10455418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC, for the Panel on Cost-Effectiveness in Health and Medicine. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276:1172-1177.
2. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, for the Panel on Cost-Effectiveness in Health and Medicine. Recom-mendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996-276:1253-1258.
3. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. CostEffectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
4. Udvarhelyi S, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med. 1992;! 16:238-244.
5. Mason J, Drummond M. Reporting guidelines for economic studies. Health Econ. 1995;4:85-94.
6. Adams ME, McCall NT, Gray DT, Orza MJ, Chalmers TC. Economic analysis in randomized control trials. Med Care. 1992;30: 231-243.
7. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York, NY: Oxford University Press; 1987.
8. Shepard DS, Thompson MS. First principles of cost-effectiveness analysis in health. Public Health Rep. 1979;94:535-543.
9. Office of Technology Assessment. The Implications of Cost-Effectiveness Analysis of Medical Technology, Congress of the United States, August 1980. Washington, DC: US Government Printing Office; 1980.
10. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. NEnglJMed 1977;296: 716-721.
11. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: a report on principles. Ann Intern Med. 1995;122:60-69.
12. Henry D. Economic analysis as an aid to subsidisation decisions: the development of Australia's guidelines for pharmaceuticals. PharmacoEconomics. 1992; 1:54-67.
13. Commonwealth Department of Human Services and Health. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee. Canberra, Australia: Australian Government Publishing Service; 1995.
14. Canadian Coordinating Office for Health Technology Assessment. Guidelines for Economic Evaluation of Pharmaceuticals: Canada. Ottawa, Ontario: Canadian Coordinating Office for Health Technology Assessment; 1994.
15. Weinstein MC. Principles of cost-effective resource allocation in health care organizations. Int J Technol Assess Health Care. 1990;6:93-103.
16. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programmes. Health Serv Res. 1972;7:118-133.
17. Cantor SB. Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment. Med Decis Making. 1994;14: 259-265.